Integer Holdings Co. (NYSE:ITGR) Receives Consensus Recommendation of "Buy" from Brokerages

Shares of Integer Holdings Co. (NYSE:ITGR - Get Free Report) have been given an average recommendation of "Buy" by the nine ratings firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $145.00.

ITGR has been the topic of a number of recent research reports. Benchmark lowered their price objective on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. KeyCorp decreased their target price on Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Oppenheimer downgraded Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and boosted their target price for the stock from $133.00 to $140.00 in a research note on Thursday, May 22nd. Finally, Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th.

Insiders Place Their Bets

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the sale, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. This represents a 87.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.16% of the stock is owned by company insiders.

Institutional Trading of Integer

Several hedge funds and other institutional investors have recently made changes to their positions in ITGR. Strs Ohio purchased a new position in Integer in the 1st quarter worth $283,000. Intech Investment Management LLC grew its position in Integer by 92.8% during the 1st quarter. Intech Investment Management LLC now owns 22,682 shares of the medical equipment provider's stock worth $2,677,000 after purchasing an additional 10,915 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Integer by 4.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider's stock worth $12,900,000 after purchasing an additional 4,873 shares during the period. Axiom Investors LLC DE acquired a new stake in Integer during the 1st quarter worth about $4,457,000. Finally, United Services Automobile Association acquired a new stake in Integer during the 1st quarter worth about $258,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Trading Down 0.4%

Shares of ITGR stock traded down $0.51 on Monday, reaching $118.99. 7,550 shares of the stock were exchanged, compared to its average volume of 371,676. The stock has a market cap of $4.15 billion, a PE ratio of 35.49, a P/E/G ratio of 1.72 and a beta of 1.03. Integer has a one year low of $104.93 and a one year high of $146.36. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The stock has a 50 day moving average price of $118.60 and a 200 day moving average price of $128.75.

Integer (NYSE:ITGR - Get Free Report) last posted its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The firm had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company's revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.14 earnings per share. Equities research analysts forecast that Integer will post 6.01 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.